Allogeneic NK cells induce the <i>in vitro</i> activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Elisa C. Toffoli(Amsterdam University Medical Centers), Tanja D. de Gruijl(Dutch Cancer Society), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Annemijn J. Arns(Amsterdam University Medical Centers), Henk W M Verheul(Erasmus MC), Jurriaan B. Tuynman(Amsterdam Neuroscience), C.D. Forbes(Amsterdam University Medical Centers), A.A. van Vliet(AIMM Therapeutics (Netherlands))
Cited by 6
Related Papers
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
|Radiology|2020|363
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|357
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326